Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 10, Octobre 2010
Page(s) 836 - 841
Section M/S revues
DOI https://doi.org/10.1051/medsci/20102610836
Publié en ligne 15 octobre 2010
  1. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000 ; 26 : 207-10.
  2. Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynaminrelated GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000 ; 26 : 211-5.
  3. Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004 ; 36 : 449-51.
  4. Waterham HR, Koster J, Van Roermund CW, et al. A lethal defect of mitochondrial and peroxisomal fission. N Eng J Med 2007 ; 356 : 1736-41.
  5. Baxter RV, Ben Othmane K, Rochelle JM, et al. Ganglioside-induced differentiation-associated protein1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet 2002 ; 30 : 21-2.
  6. Claramunt R, Pedrola L, Sevilla T, et al. Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect. J Med Genet 2005 ; 42 : 358-65.
  7. Kjer P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol 1959 ; 164 (suppl 54) : 1-147.
  8. Milea D, Sander B, Wegener M, et al. Axonal loss occurs early in dominant optic atrophy. Acta Ophthalmol 2010 ; 88 : 342-6.
  9. Yu-Wai-Man P, Griffiths PG, Gorman GS, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010 ; 133 : 771-86.
  10. Lenaers G, Reynier OPE1 Achouri G, et al. OPA1 functions in mitochondria and dysfunctions in optic nerve. Int J Biochem Cell Biol 2009 ; 41 : 1866-74.
  11. Ferré M, Amati-Bonneau P, Tourmen Y, et al. eOPA1: an online database for OPA1 mutations. Hum Mutat 2005 ; 25 : 423-8.
  12. Sauvanet C, Arnauné-Pelloquin L, David C, et al. Mitochondrial morphology and dynamics: actors, mecanisms and functions. Med Sci (Paris) 2010 ; 26 : 823-9.
  13. Chevrollier A, Guillet V, Loiseau D, et al. Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann Neurol 2008 ; 63 : 794-8.
  14. Zanna C, Ghelli A, Porcelli AM, et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008 ; 131 : 352-67.
  15. Amati-Bonneau P, Valentino ML, Reynier P, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy plus phenotypes. Brain 2008 ; 131 : 338-51.
  16. Sarzi E, Rötig A. Instabilité du génome mitochondrial et pathologies associées. Med Sci (Paris) 2010 ; 26 : 171-6.
  17. Alavi MV, Bette S, Schimpf S, et al. A splice site mutation in the murine OPA1 gene features pathology of autosomal dominant optic atrophy. Brain 2007 ; 130 : 1029-42.
  18. Davies VJ, Hollins AJ, Piechota MJ, et al. OPA1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet 2007 ; 16 : 1307-18.
  19. Charcot JM, Marie P. Sur une forme particulière d’atrophie musculaire progressive souvent familiale débutant par les pieds et les jambes et atteignant plus tard les mains. Rev Med 1886 ; 6 : 97-138.
  20. Tooth H. The peroneal type of progressive muscular atrophy. London : HK Lewis, 1886.
  21. Züchner S, De Jonghe P, Jordanova A, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol 2006 ; 59 : 276-81.
  22. Cartoni R, Martinou JC. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A. Exp Neurol 2009 ; 218 : 268-73.
  23. Vallat JM, Ouvrier RA, Pollard JD, et al. Histopathological findings in hereditary motor and sensory neuropathy of axonal type with onset in early childhood associated with mitofusin 2 mutations. J Neuropathol Exp Neurol 2008 ; 67 : 1097-102.
  24. Cartoni R, Arnaud E, Médard JJ, et al. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A. Brain 2010 ; 133 : 1460-9.
  25. Misko A, Jiang S, Wegorzewska I, et al. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci 2010 ; 30 : 4232-40.
  26. Loiseau D, Chevrollier A, Verny C, et al. Mitochondrial Coupling Defect in Charcot-Marie-Tooth Type 2A disease. Ann Neurol 2007 ; 61 : 315-23.
  27. Chen H, Vermulst M, Wang YE, et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 2010 ; 141 : 280-9.
  28. Niemann A, Ruegg M, La Padula V, et al. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol 2005 ; 170 : 1067-78.
  29. Cassereau J, Chevrollier A, Gueguen N, et al. Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K). Neurogenetics 2009 ; 10 : 145-50.
  30. Mai S, Klinkenberg M, Auburger G, et al. Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK1. J Cell Sci 2010 ; 123 : 917-26.
  31. Yang Y, Ouyang Y, Yang L, et al. Pink1 regulates mitochondrial dynamics throught interaction with the fission/fusion machinery. Proc Natl Acad Sci USA 2008 ; 105 : 7070-5.
  32. Ziviani E, Tao RN, Whitworth AJ. Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquinates mitofusin. Proc Natl Acad Sci USA 2010 ; 107 : 5018-23.
  33. Wang X, Su B, Siedlak SL, et al. Amyloid beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 2008 ; 105 : 19318-23.
  34. Wang H, Lim PJ, Karbowski M, Monteiro MJ. Effects of overexpression of Huntingtin proteins on mitochondrial integrity. Hum Mol Genet 2008 ; 18 : 737-52.
  35. Fukui H, Moraes CT. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci 2008 ; 31 : 251-6.
  36. Vallat JM, Funalot B. La maladie de Charcot-Marie-Tooth. Med Sci (Paris) 2010 ; 26 : 842-7.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.